VANGUARD GROUP INC - DURATA THERAPEUTICS INC ownership

DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 75 filers reported holding DURATA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.75 and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$4,759,000
-12.9%
375,304
+17.0%
0.00%
Q2 2014$5,465,000
+35.6%
320,867
+7.2%
0.00%
Q1 2014$4,030,000
+22.0%
299,387
+15.9%
0.00%
Q4 2013$3,303,000
+42.9%
258,271
+1.0%
0.00%
Q3 2013$2,311,000
+25.8%
255,696
+0.2%
0.00%
Q2 2013$1,837,000255,1190.00%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 508,472$4,596,0003.19%
Broadfin Capital, LLC 383,227$3,464,0000.62%
Orbimed Advisors 1,785,714$16,143,0000.29%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 275,979$2,495,0000.12%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 1,188,571$10,745,0000.10%
Lenox Wealth Advisors, LLC 8,000$72,0000.07%
STONERIDGE INVESTMENT PARTNERS LLC 30,732$278,0000.06%
Loeb Offshore Management LP 19,621$177,0000.06%
Alyeska Investment Group, L.P. 100,000$904,0000.04%
PARADIGM ASSET MANAGEMENT CO LLC 25,000$226,000,0000.04%
View complete list of DURATA THERAPEUTICS INC shareholders